Barlas, T. Et Al. 2023. Evaluation of Lipohypertrophy in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injections or Continuous Subcutaneous Insulin Infusion. ENDOCRINE PRACTICE , vol.29, no.2 , 119-126.

Barlas, T., Yalcin, M. M., Coskun, M., Demirel, D., Altinova, A., Balos Toruner, F. S., ... Karakoc, M. A.(2023). Evaluation of Lipohypertrophy in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injections or Continuous Subcutaneous Insulin Infusion. ENDOCRINE PRACTICE , vol.29, no.2, 119-126.

Barlas, TUĞBA Et Al. "Evaluation of Lipohypertrophy in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injections or Continuous Subcutaneous Insulin Infusion," ENDOCRINE PRACTICE , vol.29, no.2, 119-126, 2023

Barlas, TUĞBA Et Al. "Evaluation of Lipohypertrophy in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injections or Continuous Subcutaneous Insulin Infusion." ENDOCRINE PRACTICE , vol.29, no.2, pp.119-126, 2023

Barlas, T. Et Al. (2023) . "Evaluation of Lipohypertrophy in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injections or Continuous Subcutaneous Insulin Infusion." ENDOCRINE PRACTICE , vol.29, no.2, pp.119-126.

@article{article, author={TUĞBA BARLAS Et Al. }, title={Evaluation of Lipohypertrophy in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injections or Continuous Subcutaneous Insulin Infusion}, journal={ENDOCRINE PRACTICE}, year=2023, pages={119-126} }